Get the Stockscreener App
0.62
0.81%
0.005
After Hours:
.62
Retractable Technologies Inc stock is traded at $0.62, with a volume of 13,433.
It is up +0.81% in the last 24 hours and down -15.72% over the past month.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps. The company also develops EasyPoint needles. In addition, it is developing retractable needles and syringes, glass syringes, dental syringes, and IV catheter introducers. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.
See More
Previous Close:
$0.615
Open:
$0.63
24h Volume:
13,433
Relative Volume:
0.17
Market Cap:
$18.56M
Revenue:
$38.25M
Net Income/Loss:
$-17.87M
P/E Ratio:
-8.8571
EPS:
-0.07
Net Cash Flow:
$4.33M
1W Performance:
-0.83%
1M Performance:
-15.72%
6M Performance:
-32.97%
1Y Performance:
-46.09%
1-Day Range:
$0.6126
$0.644
1-Week Range:
$0.596
$0.644
52-Week Range:
$0.5649
$1.34
Retractable Technologies Inc Stock (RVP) Company Profile
Name
Retractable Technologies Inc
Sector
Industry
Phone
972-294-1010
Address
511 Lobo Lane, Little Elm, TX
Compare RVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVP
Retractable Technologies Inc
|
0.62 | 18.56M | 38.25M | -17.87M | 4.33M | -0.61 |
|
ISRG
Intuitive Surgical Inc
|
542.00 | 193.05B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
221.90 | 64.77B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
88.85 | 43.95B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
249.02 | 36.58B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
325.68 | 23.63B | 2.88B | 499.60M | 321.60M | 6.74 |
Retractable Technologies Inc Stock (RVP) Latest News
Safety Syringes Market: Safeguarding Healthcare with Advanced Needle Safety Solutions - openPR
Retractable Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Retractable Technologies reports loss of USD 5.1M in Q3 2024 - Medical Buyer
Retractable Technologies: Q3 Earnings Snapshot - New Haven Register
Retractable Technologies Inc (RVP) Quarterly 10-Q Report - Quartzy
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - The Bakersfield Californian
Retractable Technologies Reports Steep Q3 Loss as Margins Collapse, Tariffs Bite | RVP Stock News - StockTitan
Retractable Technologies CEO Thomas Shaw acquires $5,422 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock By Investing.com - Investing.com Australia
RVP stock touches 52-week low at $0.7 amid market challenges - Investing.com Australia
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock - Investing.com India
Disposable Syringes Market Overall Study Report 2024-2031 | B. - openPR
Feds Can Hold Proceeds During Chinese Syringe Duties Fight - Law360
Retractable Technologies CEO Thomas J. Shaw acquires $6,876 in stock - Investing.com
Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock By Investing.com - Investing.com UK
Retractable Technologies stock hits 52-week low at $0.71 By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw buys shares for $429 - Investing.com
Retractable Technologies CEO Thomas Shaw buys shares for $429 By Investing.com - Investing.com Australia
Retractable Technologies stock hits 52-week low at $0.71 - Investing.com India
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock By Investing.com - Investing.com Australia
Retractable Technologies CEO Shaw buys $6,061 in stock By Investing.com - Investing.com South Africa
Retractable Technologies CEO Shaw buys $6,061 in stock - Investing.com
Safety Syringes Market 2024-2031 Global Industry Analysis, - openPR
Smart Syringes Market Projected to Surge to USD 143.93 Million by 2031 - WhaTech
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock - Investing.com India
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock By Investing.com - Investing.com South Africa
Hypodermic Needles Market Generated Opportunities, Future - openPR
Venous Blood Collection Market to Witness Huge Growth by 2032 |Terumo, BD, Bio Rad Laboratories, Nipro - openPR
Retractable sues Becton alleging patent infringement - Reuters
Disposable Syringes Market Forecasting Dynamic Growth: - openPR
Smart Syringes Industry: Insights from Latest Research Report on Business Opportunities by (2024-2034) - IndiaPolitics.com
U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of - Daily Guardian Canada
Retractable Technologies Inc Stock (RVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):